GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (NYSE:PBH) » Definitions » Cyclically Adjusted PS Ratio

Prestige Consumer Healthcare (Prestige Consumer Healthcare) Cyclically Adjusted PS Ratio : 3.25 (As of Apr. 27, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Prestige Consumer Healthcare's current share price is $70.47. Prestige Consumer Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $21.65. Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio for today is 3.25.

The historical rank and industry rank for Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio or its related term are showing as below:

PBH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.05   Med: 3.18   Max: 5.83
Current: 3.24

During the past years, Prestige Consumer Healthcare's highest Cyclically Adjusted PS Ratio was 5.83. The lowest was 2.05. And the median was 3.18.

PBH's Cyclically Adjusted PS Ratio is ranked worse than
66.71% of 736 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs PBH: 3.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Prestige Consumer Healthcare's adjusted revenue per share data for the three months ended in Dec. 2023 was $5.641. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $21.65 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Chart

Prestige Consumer Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.18 2.43 2.66 2.77 3.02

Prestige Consumer Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.10 3.02 2.81 2.66 2.83

Competitive Comparison of Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio falls into.



Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=70.47/21.65
=3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Consumer Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Prestige Consumer Healthcare's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=5.641/129.4194*129.4194
=5.641

Current CPI (Dec. 2023) = 129.4194.

Prestige Consumer Healthcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 2.715 99.695 3.525
201406 2.774 100.560 3.570
201409 3.447 100.428 4.442
201412 3.748 99.070 4.896
201503 3.598 99.621 4.674
201506 3.628 100.684 4.663
201509 3.877 100.392 4.998
201512 3.763 99.792 4.880
201603 3.903 100.470 5.028
201606 3.963 101.688 5.044
201609 4.031 101.861 5.122
201612 4.062 101.863 5.161
201703 4.504 102.862 5.667
201706 4.795 103.349 6.005
201709 4.819 104.136 5.989
201712 5.054 104.011 6.289
201803 4.783 105.290 5.879
201806 4.797 106.317 5.839
201809 4.590 106.507 5.577
201812 4.625 105.998 5.647
201903 4.643 107.251 5.603
201906 4.460 108.070 5.341
201909 4.685 108.329 5.597
201912 4.752 108.420 5.672
202003 4.938 108.902 5.868
202006 4.515 108.767 5.372
202009 4.686 109.815 5.523
202012 4.723 109.897 5.562
202103 4.707 111.754 5.451
202106 5.312 114.631 5.997
202109 5.438 115.734 6.081
202112 5.389 117.630 5.929
202203 5.237 121.301 5.588
202206 5.461 125.017 5.653
202209 5.755 125.227 5.948
202212 5.490 125.222 5.674
202303 5.740 127.348 5.833
202306 5.564 128.729 5.594
202309 5.717 129.860 5.698
202312 5.641 129.419 5.641

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Prestige Consumer Healthcare  (NYSE:PBH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Consumer Healthcare (Prestige Consumer Healthcare) Business Description

Traded in Other Exchanges
Address
660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Executives
Mary Beth Fritz officer: Senior VP Quality & Regulatory 660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Ronald M. Lombardi officer: Chief Executive Officer 660 WHITE PLAINS RD., TARRYTOWN NY 10591
James Darecca director C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Christine Sacco officer: Chief Financial Officer C/O SMART BALANCE, INC., 115 WEST CENTURY ROAD, SUITE 260, PARAMUS NJ 07652
Adel Mekhail other: EVP, Marketing & Sales 660 WHITE PLAINS RD., 2ND FL, TARRYTOWN NY 10591
William P'pool officer: See Remarks 2400 WEST LLOYD EXPRESSWAY, EVANSVILLE IL 47721
Celeste A. Clark director C/O ADVANCEPIERRE FOODS HOLDINGS, INC., 9987 CARVER ROAD, BLUE ASH OH 45242
Christopher J Coughlin director
Natale S Ricciardi director C/O MORRIS COMMUNICATIONS CORP, 725 BROAD ST., AUGUSTA GA 30903
James M Jenness director PO BOX 3599, BATTLECREEK MI 49016-3599
John E Byom director 660 WHITE PLAINS RD., TARRYTOWN NY 10591
Sheila Hopkins director C/O WARNACO INC, 90 PARK AVENUE, NEW YORK NY 10016
Dawn M. Zier director 600 OFFICE CENTER DRIVE, FORT WASHINGTON PA 19034
Jeffrey Zerillo officer: Senior VP Operations 660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Timothy Connors officer: Chief Marketing Officer 660 WHITE PLAINS RD., SUITE 205, TARRYTOWN NY 10591